The Grady Liver Clinic - Atlanta, GA United States
Health outcomes additional info
25% reduction in HCV prevalence by 2022
Performance target additional info
HCV Testing: Test 90% of baby boomers by 2021; HCV diagnosis: Test 99% of HCV Ab + patients for HCV RNA by 2021; Referred for treatment: Refer 90% of eligible patients for HCV treatment by 2021; HCV Treatment: Achieve >95% cure rate among those who initiate treatment and are tested for cure by 2021
Summary and objectives
The Grady Liver Clinic (GLC) has become a model of excellence for non-traditional approaches to hepatitis C care, as it provides access for patients with healthcare disparities. Founded in 2002, the GLC is based at Grady Memorial Hospital, part of a safety-net health system in Atlanta, GA. The GLC is an innovative model for HCV care in that it is primary care-based and staffed by general internists with expertise in HCV management. Using a multidisciplinary team approach including physicians, clinical pharmacists, nurses and patient navigators and a coordinator, the GLC has successfully implemented large scale hepatitis C screening and linkage to care as well as treatment programs. We have tested almost 34,000 patients for hepatitis C, revealed a 9% prevalence of infection, and we currently treat approximately 500 patients annually with a 98% cure rate.